Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Tesla Needs a Big Beat to Get Back to $1 Trillion Value

Published 01/26/2022, 06:40 AM
Updated 01/26/2022, 08:45 AM
© Reuters Tesla Needs a Big Beat to Get Back to $1 Trillion Value
US500
-
GM
-
MSFT
-
F
-
BIDU
-
ATVI
-
NVDA
-
NFLX
-
TSLA
-
PTON
-
RIVN
-

(Bloomberg) -- Pole position in the electric-vehicle business and a high valuation means Tesla Inc. (NASDAQ:TSLA) needs to deliver a blowout quarter to reclaim its trillion-dollar market value.

Tesla’s estimate-beating production and delivery stats have helped boost its projected revenue growth to 46% in 2022, a far cry compared to 20% for General Motors Co. (NYSE:GM) and 15% for Ford Motor Co . (NYSE:F). The problem is, even after the stock slumped 25% from its November record, Tesla’s dizzying market capitalization of $922 billion is more than 10 times the size of those 100-plus year old Detroit giants.

For Lindsey Bell, chief markets & money strategist at Ally Invest Securities, Tesla’s size only makes it more susceptible to violent market gyrations amid an environment of rising interest rates. 

The broader meltdown in high-growth stocks, spurred by the Federal Reserve’s hawkish stance on monetary policy, adds to the headache for Tesla, which trades at 94 times forward earnings -- among the 10 most expensive members of the S&P 500 Index. What’s more, the specter of aggressive competition could hurt its pricing power as GM, Ford and new entrants such as Rivian Automotive Inc (NASDAQ:RIVN) roll out more electric vehicles.

“If 2022 ends up being a year of more cautiousness toward some of the historical star performers, it is difficult to see why Tesla won’t get caught up in that,” David Jones, chief market strategist at Capital.com, said in an interview. 

Even strong fourth-quarter numbers could go only so far in soothing investors’ nervousness about the stock, given its whopping 27,000% run since Tesla went public in 2010.

Wall Street analysts, in aggregate, see the stock going nowhere over the next year: The average price target tracked by Bloomberg is $953, an increase of 4% from Tuesday’s close.

For Wedbush’s Daniel Ives, who has a $1,400 target, the focus on Wednesday’s earnings will be around commentary on deliveries in 2022, the shortage of semiconductors, when production will begin at new factories in Austin, Texas, and Berlin, and the company’s growth and profitability outlook for this year and beyond.

“We believe the emerging fundamental story at Tesla will be back in focus of the Street with currently demand outstripping supply for Musk & Co. by roughly 30% globally based on our estimates,” he wrote in a note.

Tech Chart of the Day

After Peloton Interactive (NASDAQ:PTON) Inc., Netflix Inc (NASDAQ:NFLX). has now wiped out almost all of its pandemic gains, leaving shares at almost half the record high in November after its poor outlook last week. Shares of the pandemic-era trading favorites have gotten caught up in a widespread rotation out of growth stocks, as concerns over inflation and Federal Reserve tightening have made investors less tolerant of high-valuation names.

Top Tech Stories

  • Microsoft (NASDAQ:MSFT) shares rose in late trading after the software giant gave a forecast that reassured investors the company’s Azure cloud-computing business still has potential to drive growth
  • SoftBank shares bounced from a 52-week low a day earlier as Nvidia (NASDAQ:NVDA) considers walking away from its deal to buy Arm from the Japanese investment giant
  • China’s Baidu (NASDAQ:BIDU) and Zhejiang Geely Holding backed a nearly $400 million financing round for smart-car maker Jidu Auto, which Baidu spun off last year in a multibillion-dollar push into electric vehicles
  • Activision Blizzard (NASDAQ:ATVI), which is being bought by Microsoft, will release at least the next three games in its hit Call of Duty franchise on Sony’s PlayStation as well as its new owner’s Xbox
  • Singapore attracted $8.8 billion in investment commitments last year, led by semiconductor manufacturers ramping up production to meet a global chip shortage and biotechnology firms chasing pandemic demand

©2022 Bloomberg L.P.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.